CA58490H1073 - MDNA (XNAS)
MEDICENNA THERAPEUTICSCS CORP Aktie
Performance
Tag | Woche | Monat | 3 Monate | 6 Monate | 1 Jahr | 5 Jahre |
---|---|---|---|---|---|---|
- | - | - | - | 0,00 % | 23,73 % | -67,41 % |
Firmenprofil zu MEDICENNA THERAPEUTICSCS CORP Aktie
Medicenna Therapeutics Corp., an immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer and other diseases. Its lead product is MDNA55, an interleukin- 4 (IL-4) EC that has completed Phase IIb clinical trial for the treatment of recurrent glioblastoma, as well as preclinical and clinical development stages for the treatment of other brain and non-brain tumors. The company also develops MDNA11, an enhanced version of IL-2 to activate and proliferate the immune cells needed to fight cancer; MDNA209, an IL-2 antagonist for autoimmune diseases, such as multiple sclerosis and graft versus host disease; MDNA413, a dual IL-4/IL-13 antagonist to treat cancer immunotherapies; and MDNA132, an IL-13 Superkine for solid tumors. In addition, it provides BiSKITs platform to develop designer Superkines by fusing them to other proteins, antibodies, cytokines, or other Superkines. The company is headquartered in Toronto, Canada.
Unternehmensdaten zur MEDICENNA THERAPEUTICSCS CORP Aktie
Name MEDICENNA THERAPEUTICSCS CORP
Firma Medicenna Therapeutics Corp.
Symbol MDNA
Website https://www.medicenna.com
Heimatbörse
NASDAQ
ISIN CA58490H1073
Wertpapierart Aktie
Sektor Healthcare
Branche Biotechnology
CEO Dr. Fahar Merchant Ph.D.
Land Kanada
Währung USD
Mitarbeiter 0,0 T
Adresse 2 Bloor Street West, M4W 3E2 Toronto
IPO Datum 2017-11-13
Ticker Symbole
Name | Symbol |
---|---|
NASDAQ | MDNA |
Weitere Aktien
Investoren die MEDICENNA THERAPEUTICSCS CORP halten haben auch folgende Aktien im Depot:
Die Finanzplattform goSPATZ trackt und analysiert Investitionen und Portfolios.
Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
All rights reserved © LCP GmbH 2024